Clinical Scorecard: Scaling Smarter: How Continuous Manufacturing Is Reshaping Drug Development

At a Glance

Key Highlights

• Twin-screw extruders maintain uniform process parameters across scales, ensuring product consistency.
• Real-time monitoring enhances control over extrusion processes, reducing batch-to-batch variability.
• Continuous granulation and 3D printing streamline manufacturing and reduce processing errors.
• Precision and repeatability are critical for patient safety and regulatory compliance.
• Flexible systems are essential for biotechs targeting rare diseases with limited quantities of APIs.

Guideline-Based Recommendations

Diagnosis

Management

• Utilize twin-screw extrusion for consistent mixing and processing.
• Implement real-time monitoring to catch deviations immediately.

Monitoring & Follow-up

• Track torque, temperature, and pressure continuously during the extrusion process.

Risks

• Variability in drug formulation can lead to rejected batches and patient safety issues.

Patient & Prescribing Data

Patients with complex or rare diseases requiring precise medication formulations.

Advanced technologies enable the production of fixed-dose combinations and tailored therapies.

Clinical Best Practices

• Run processes adiabatically to maintain predictable scale-up behavior.
• Match specific mechanical energy consumption (SMEC) across scales.
• Document all development processes, including failures, to identify critical boundaries.

References